Question 1

What is the catalog number for HLA Class 2 Antigen DR (HLA-DR) (APC)?

Accepted Answer

The catalog number for HLA Class 2 Antigen DR (HLA-DR) (APC) is MBS6260870.

Question 2

What sizes are available for HLA Class 2 Antigen DR (HLA-DR) (APC)?

Accepted Answer

HLA Class 2 Antigen DR (HLA-DR) (APC) is available in the following size(s): 0.1 mL, 5x 0.1 mL.

Question 3

How many pack sizes does HLA Class 2 Antigen DR (HLA-DR) (APC) come in?

Accepted Answer

HLA Class 2 Antigen DR (HLA-DR) (APC) is available in 2 different pack sizes.

Question 4

Is HLA Class 2 Antigen DR (HLA-DR) (APC) in stock?

Accepted Answer

HLA Class 2 Antigen DR (HLA-DR) (APC) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

HLA Class 2 Antigen DR (HLA-DR) (APC)

Product Specifications

CAS Number

Gene Name

Reactivity

Storage Conditions

Specificity

Short Name

Available Sizes

Frequently Asked Questions

Explore Other Products

P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Biotin conjugate, 0.1mg/mL

BBS9 Rabbit Polyclonal Antibody

Chlorotriethoxysilane

Human ULBP2 activation kit by CRISPRa

P53 (Tumor Suppressor Protein) (TP53/2719), 0.2mg/mL

IL6 Human Gene Knockout Kit (CRISPR)